Paroxysmal nocturnal hemoglobinuria (PNH) is an uncommon and life-threatening blood disorder. Hemolytic anemia or loss of red blood cells, thrombosis (blood clots), and bone marrow dysfunction are symptoms of the condition. PNH is a condition that predominantly affects young individuals and affects 1-1.5 people per million.
In a bone marrow stem cell, mutations produce PNH in the PIG-A gene. Stem cells create all adult blood products, including red blood cells that transport oxygen to our organs, white blood cells that fight infection, and platelets that aid in the formation of blood clots. In PNH, the PIG-A mutation is passed down from the afflicted stem cell to all cells generated from the aberrant stem cell. PIG-A mutations cause a deficiency in GPI-anchored proteins, which are a kind of protein. Specific GPI-anchored proteins protect red blood cells from destruction, while others aid blood coagulation and infection resistance.
PNH is caused by a genetic abnormality that has been found. Researchers will be able to investigate the condition in previously impossible ways. They may get insight into building more effective medications due to their discovery of the genetic flaw.